Joachim R. Gruber
Medical Practice at Dixie Ave, Glendale, KY
License number
Kentucky 37236
Issued Date
Jun 20, 2002
Expiration Date
Feb 28, 2018
Category
Emergency Medicine
Type
Hospital Based
Address
Address
913 Dixie Ave, Glendale, KY 42701
Education
Boston University School of Medicine, 1999
Phone
(270) 706-1642 (Work)
Personal information
See more information about Joachim R. Gruber at radaris.comName
Address
Phone
105 Deer Grove Ct, Elizabethtown, KY 42701
Elizabethtown, KY
105 Deer Grove Rd, Elizabethtown, KY 42701
Professional information
See more information about Joachim R. Gruber at trustoria.com
Joachim R Gruber, Elizabethtown KY
Joachim R Gruber, Elizabethtown KY
Specialties:
Emergency Medicine Physician
Address:
913 N Dixie Ave, Elizabethtown, KY 42701
Education:
Boston University, School of Medicine - Doctor of Medicine
Boston University - Doctor of Philosophy
Boston University - Doctor of Philosophy
Board certifications:
American Board of Emergency Medicine Certification in Emergency Medicine
Dr. Joachim Gruber, Elizabethtown KY - MD (Doctor of Medicine)
Dr. Joachim Gruber, Elizabethtown KY - MD (Doctor of Medicine)
Specialties:
Emergency Medicine
Address:
913 N Dixie Ave SUITE 913, Elizabethtown 42701
(270) 706-1642 (Phone), (270) 706-1099 (Fax)
(270) 706-1642 (Phone), (270) 706-1099 (Fax)
Certifications:
Emergency Medicine, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
913 N Dixie Ave SUITE 913, Elizabethtown 42701
Hardin Memorial Hospital
913 North Dixie Ave, Elizabethtown 42701
Hardin Memorial Hospital
913 North Dixie Ave, Elizabethtown 42701
Education:
Medical School
Boston University School of Medicine
Graduated: 1999
Parkland Hosp/ Univ Tx Sw Mc
Parkland Hosp/Univ Of Tx Sw Mc
Boston University School of Medicine
Graduated: 1999
Parkland Hosp/ Univ Tx Sw Mc
Parkland Hosp/Univ Of Tx Sw Mc
Keratinocyte Growth Factor-2
Keratinocyte Growth Factor-2
US Patent:
2003018, Oct 2, 2003
Filed:
Jan 4, 2002
Appl. No.:
10/035212
Inventors:
Steven Ruben - Olney MD, US
Pablo Jimenez - Chatham NJ, US
Roxanne Duan - Bethesda MD, US
Mark Rampy - Montgomery Village MD, US
Donna Mendrick - Mount Airy MD, US
Jun Zhang - Bethesda MD, US
Jian Ni - Rockville MD, US
Paul Moore - Germantown MD, US
Timothy Coleman - Gaithersburg MD, US
Joachim Gruber - Elizabethtown KY, US
Patrick Dillon - Carlsbad CA, US
Reiner Gentz - Rockville MD, US
Pablo Jimenez - Chatham NJ, US
Roxanne Duan - Bethesda MD, US
Mark Rampy - Montgomery Village MD, US
Donna Mendrick - Mount Airy MD, US
Jun Zhang - Bethesda MD, US
Jian Ni - Rockville MD, US
Paul Moore - Germantown MD, US
Timothy Coleman - Gaithersburg MD, US
Joachim Gruber - Elizabethtown KY, US
Patrick Dillon - Carlsbad CA, US
Reiner Gentz - Rockville MD, US
Assignee:
HUMAN GENOME SCIENCES, INC.
International Classification:
A61K048/00, A61K038/18, C12N005/08
US Classification:
514/044000, 514/012000, 435/366000
Abstract:
This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides. More particularly, the polypeptide of the present invention is a Keratinocyte Growth Factor, sometimes hereinafter referred to as “KGF-2” also formerly known as Fibroblast Growth Factor 12 (FGF-12). This invention further relates to the therapeutic use of KGF-2 to promote or accelerate wound healing. This invention also relates to novel mutant forms of KGF-2 that show enhanced activity, increased stability, higher yield or better solubility.